Literature DB >> 25631770

The role of thrombolytic therapy in pulmonary embolism.

Tzu-Fei Wang1, Alessandro Squizzato2, Francesco Dentali2, Walter Ageno2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25631770      PMCID： PMC4383796          DOI： 10.1182/blood-2014-08-559278

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  40 in total

1.  Estimated case fatality rate of pulmonary embolism, 1979 to 1998.

Authors:  Paul D Stein; Fadi Kayali; Ronald E Olson
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

2.  Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study.

Authors: 
Journal:  JAMA       Date:  1974-09-16       Impact factor: 56.272

3.  Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.

Authors:  U Tebbe; A Graf; W Kamke; R Zahn; F Forycki; G Kratzsch; G Berg
Journal:  Am Heart J       Date:  1999-07       Impact factor: 4.749

4.  Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.

Authors:  N Meneveau; F Schiele; A Vuillemenot; B Valette; G Grollier; Y Bernard; J P Bassand
Journal:  Eur Heart J       Date:  1997-07       Impact factor: 29.983

5.  Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.

Authors:  S Z Goldhaber; C M Kessler; J A Heit; C G Elliott; W R Friedenberg; D E Heiselman; D B Wilson; J A Parker; D Bennett; M L Feldstein
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

6.  Venous thromboembolism in adult hospitalizations - United States, 2007-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-08       Impact factor: 17.586

7.  Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.

Authors:  Saurav Chatterjee; Anasua Chakraborty; Ido Weinberg; Mitul Kadakia; Robert L Wilensky; Partha Sardar; Dharam J Kumbhani; Debabrata Mukherjee; Michael R Jaff; Jay Giri
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

8.  Desmoteplase in acute massive pulmonary thromboembolism.

Authors:  Ulrich Tebbe; Peter Bramlage; Andreas Graf; Peter Lechleitner; Christoph Bode; Friedrich-Christian Riess; Norbert Clemens; Yasir Al-Rawi; Stavros Konstantinides; Samuel Z Goldhaber
Journal:  Thromb Haemost       Date:  2009-03       Impact factor: 5.249

9.  Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.

Authors:  S Z Goldhaber; C M Kessler; J Heit; J Markis; G V Sharma; D Dawley; J S Nagel; M Meyerovitz; D Kim; D E Vaughan
Journal:  Lancet       Date:  1988-08-06       Impact factor: 79.321

10.  Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.

Authors:  D A Tibbutt; J A Davies; J A Anderson; E W Fletcher; J Hamill; J M Holt; M L Thomas; G Lee; G A Miller; A A Sharp; G C Sutton
Journal:  Br Med J       Date:  1974-03-02
View more
  12 in total

Review 1.  On the right side of the heart: Medical and mechanical support of the failing right ventricle.

Authors:  Ignacio de Asua; Alex Rosenberg
Journal:  J Intensive Care Soc       Date:  2017-01-03

2.  Thrombosis.

Authors:  Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 3.  Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.

Authors:  Matthew A Chiarello; Akhilesh K Sista
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

4.  Comorbid cancer and use of thrombolysis in acute pulmonary embolism.

Authors:  Erin R Weeda; Kevin M Hakamiun; Hannah X Leschorn; Emmeline Tran
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

Review 5.  Pediatric Thrombolysis: A Practical Approach.

Authors:  Cristina Tarango; Marilyn J Manco-Johnson
Journal:  Front Pediatr       Date:  2017-12-06       Impact factor: 3.418

Review 6.  Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.

Authors:  Paul Abraham; Diego A Arroyo; Raphael Giraud; Henri Bounameaux; Karim Bendjelid
Journal:  Open Heart       Date:  2018-02-26

7.  Successful Treatment of Refractory Massive Pulmonary Embolism with Repeated Administration of Systemic Thrombolysis.

Authors:  Armeen D Poor; Hooman D Poor
Journal:  Tanaffos       Date:  2018-02

Review 8.  Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?

Authors:  Amyn Bhamani; Joanna Pepke-Zaba; Karen Sheares
Journal:  F1000Res       Date:  2019-03-25

9.  Local Thrombolysis in High-Risk Pulmonary Embolism-13 Years Single-Center Experience.

Authors:  Liviu Macovei; Razvan Mihai Presura; Robert Magopet; Cristina Prisecariu; Carmen Macovei; Gabriela Omete; Igor Nedelciuc; Mircea Balasanian
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 10. 

Authors:  José Manuel Ceresetto; Marcos Arêas Marques
Journal:  J Vasc Bras       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.